Starling Oncology, Inc. (STLN) insider trading

By person

17 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Jorey Chernett

10% owner

—

10,660,858

$69.43M

+8.0%

M33 Growth I L.P.

Director

—

5,444,207

$35.46M

−64.3%

Richard A Barasch

Director

—

4,571,022

$29.77M

+101.2%

Daniel Virnich

Chief Executive Officer

—

2,337,166

$15.22M

+3.5%

Robert Ross Carter

Chief Financial Officer

—

649,975

$4.23M

−3.4%

Mark L Pacala

Director

—

511,852

$3.33M

+42.2%

Brad Hively

Director

—

411,976

$2.68M

−45.2%

Gabriel Ling

Director

—

333,539

$2.17M

+383.0%

Anne McGeorge

Director

—

332,535

$2.17M

+161.1%

Karen Marie Johnson

Director

—

319,410

$2.08M

+177.3%

Yale Podnos

Chief Medical Officer

—

259,527

$1.69M

+148.7%

Jeremy Castle

Chief Operating Officer

—

247,031

$1.61M

+199.6%

Mohit Kaushal

Director

—

205,716

$1.34M

+69.7%

Kristin England

Chief Administrative Officer

—

153,780

$1.00M

—

Jeffrey Langsam

Chief Clinical Officer

—

127,650

$831.33K

—

Mark Stolper

Director

—

56,957

$370.94K

—

Kimberly Jo Tzoumakas

Director

—

46,301

$301.54K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Starling Oncology, Inc.

What the insiders did No buying or selling

By person